IQVIA Holdings (IQV) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US46266C1053

Analytics, Technology, Clinical Research, Consulting, Sales

IQVIA Holdings Inc. is a leading provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry worldwide. With operations spanning the Americas, Europe, Africa, and the Asia-Pacific, the company plays a vital role in helping pharmaceutical, biotechnology, device and diagnostic, and consumer health companies bring new treatments and products to market.

The company operates through three main segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of innovative solutions, including cloud-based applications, real-world evidence, and strategic consulting services. These solutions enable life sciences companies to make informed decisions, improve patient outcomes, and optimize their commercial processes.

One of the key offerings of this segment is its ability to provide country-level insights on pharmaceutical sales, prescribing trends, and medical treatment patterns. This includes detailed data on sales performance, prescribing activity, and promotional efforts at the regional, zip code, and individual prescriber level. This level of granularity helps life sciences companies refine their marketing strategies and improve their overall commercial performance.

The Research & Development Solutions segment is dedicated to supporting clinical trials and research initiatives. This includes project management, clinical monitoring, and strategic planning services, as well as a range of laboratory services, including central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. This segment helps life sciences companies navigate the complex process of bringing new treatments and products to market.

The Contract Sales & Medical Solutions segment focuses on health care provider and patient engagement services, as well as scientific strategy and medical affairs services. This segment helps life sciences companies build strong relationships with health care providers and patients, and provides strategic guidance on medical affairs and scientific strategy.

IQVIA Holdings Inc. has a strong track record of collaboration, including a partnership with argenx SE. The company was previously known as Quintiles IMS Holdings, Inc. and rebranded as IQVIA Holdings Inc. in November 2017. Headquartered in Durham, North Carolina, IQVIA Holdings Inc. is a global leader in the life sciences industry, with a strong commitment to innovation, customer service, and improving patient outcomes.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for IQVIA Holdings (IQV) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for IQVIA Holdings (IQV) - Stock Price & Dividends

IQV Stock Overview

Market Cap in USD 39,944m
Sector Healthcare
Industry Diagnostics & Research
GiC SubIndustry Life Sciences Tools & Services
TER 0.00%
IPO / Inception 2013-05-09

IQV Stock Ratings

Growth 5y 29.8
Fundamental 30.5
Dividend -
Rel. Performance vs Sector -1.26
Analysts 4.48/5
Fair Price Momentum 181.36 USD
Fair Price DCF 244.30 USD

IQV Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

IQV Growth Ratios

Growth 12m -0.75%
Growth Correlation 12m 26%
Growth Correlation 3m -74%
CAGR 5y 6.65%
CAGR/Mean DD 5y 0.46
Sharpe Ratio 12m -0.22
Alpha vs SP500 12m -36.18
Beta vs SP500 5y weekly 1.42
ValueRay RSI 18.88
Volatility GJR Garch 1y 25.09%
Price / SMA 50 -6.36%
Price / SMA 200 -3.47%
Current Volume 1014.2k
Average Volume 20d 1256.4k

External Links for IQV Stock

Wall Street JournalBenzingaYahoo Finance
Fund Manager Positions
What is the price of IQV stocks?
As of June 18, 2024, the stock is trading at USD 213.32 with a total of 1,014,155 shares traded.
Over the past week, the price has changed by -1.16%, over one month by -7.73%, over three months by -15.97% and over the past year by -1.25%.
What are the forecast for IQV stock price target?
According to ValueRays Forecast Model, IQV IQVIA Holdings will be worth about 200.7 in June 2025. The stock is currently trading at 213.32. This means that the stock has a potential downside of -5.93%.
Issuer Forecast Upside
Wallstreet Target Price 271.2 27.1
Analysts Target Price 247.2 15.9
ValueRay Target Price 200.7 -5.93